PMID: 11918552Mar 29, 2002Paper

Reversion of autoimmune lymphoproliferative syndrome with an antimalarial drug: preliminary results of a clinical cohort study and molecular observations

British Journal of Haematology
Jutte van der Werff Ten BoschJacques Otten

Abstract

Autoimmune lymphoproliferative syndrome (ALPS) is a paediatric disease characterized by lymphoproliferation and autoimmunity. Most patients are known to carry heterozygous mutations of the TNFRSF6 gene leading to diminished Fas-mediated apoptosis and failure of activated lymphocytes to undergo apoptosis. A subgroup of patients without the TNFRSF6 gene mutation has similar defective apoptosis and clinical features. No effective treatment has been reported so far. Glucocorticoids, intravenous immunoglobulin and/or immunosuppressive drugs have usually led to only transient clinical improvement. Seven ALPS patients (two type Ia and five type III) were treated with the antimalarial drug Fansidar. No toxicity was observed. An objective response was seen in six of them and, in two, the treatment was stopped without reappearance of the symptoms. Moreover, a marked decrease in interleukin-10 levels was observed in two patients during the treatment. We found that the drug induced apoptosis in activated lymphocytes through activation of the mitochondrial apoptotic pathway.

References

Aug 1, 1992·The Journal of Clinical Investigation·M C SnellerW Strober
Jan 1, 1987·British Journal of Pharmacology·R KumarI P Stolerman
Dec 17, 1985·Journal of Immunological Methods·J Lagacé, B R Brodeur
Jan 1, 1987·International Journal of Immunopharmacology·I C BygbjergK Bendtzen
Jun 1, 1967·The Journal of Pediatrics·V C Canale, C H Smith
Feb 2, 1995·Nature·J DheinP H Krammer
Nov 1, 1995·The Journal of Experimental Medicine·P GarroneJ Banchereau
Jan 1, 1994·The Journal of Clinical Investigation·Y Levy, J C Brouet
Sep 1, 1996·The Journal of Clinical Investigation·J WuJ D Mountz
Jan 1, 1997·Immunology Today·G KroemerS A Susin
Sep 1, 1996·The Journal of Experimental Medicine·P MarchettiG Kroemer
Aug 1, 1997·European Journal of Immunology·M BenkerrouA Fischer
Aug 29, 1998·Bone Marrow Transplantation·B J SleightC L Sidman
Nov 12, 1998·The American Journal of Pathology·M S LimE S Jaffe
Nov 13, 1998·Proceedings of the National Academy of Sciences of the United States of America·T S ZhengR A Flavell
Mar 26, 1999·American Journal of Human Genetics·C E JacksonJ M Puck
Apr 3, 1999·Annals of Internal Medicine·S E StrausW Strober
Sep 29, 1999·Advances in Experimental Medicine and Biology·K M Debatin
Oct 16, 1999·British Journal of Haematology·J van der Werff ten BoschK Thielemans
Dec 11, 1999·Current Opinion in Pediatrics·C E Jackson, J M Puck
Dec 29, 2000·Pediatric Clinics of North America·J J BleesingT A Fleisher
May 9, 2001·Leukemia & Lymphoma·J Van Der Werff Ten BoschK Thielemans

❮ Previous
Next ❯

Citations

Feb 3, 2005·Cell Biology and Toxicology·A Abou-Eisha, M Afifi
Mar 12, 2008·Clinical Reviews in Allergy & Immunology·Heather K Lehman, Mark Ballow
Mar 9, 2006·Hematology·V Koneti Rao, Stephen E Straus
Feb 4, 2011·The Journal of Infectious Diseases·Philip E ThumaVictor R Gordeuk
Jun 24, 2003·Current Opinion in Rheumatology·Michael C SnellerStephen E Straus
Mar 23, 2006·Annual Review of Immunology·Nicolas BidèreMichael J Lenardo
Oct 11, 2007·Blood·David T TeacheyStephan A Grupp
Apr 14, 2006·British Journal of Haematology·Austen WorthH Bobby Gaspar
Jan 11, 2007·Scandinavian Journal of Immunology·A Ramos-AvilaM Legorreta-Herrera
Jul 10, 2009·Pediatric Blood & Cancer·Mihailo Dragana JanićJanko Nada Kraguljac Kurtović
Nov 26, 2009·British Journal of Haematology·David T TeacheyStephan A Grupp
Mar 1, 2003·Paediatric Drugs·Jutte van der Werff ten Bosch
May 4, 2016·Paediatric Drugs·Lindsey A George, David T Teachey
Jan 11, 2005·Current Opinion in Allergy and Clinical Immunology·João B Oliveira, Thomas Fleisher
Jul 3, 2008·Cancer Research·Anna Maria GiammarioliMarina Pierdominici
Nov 20, 2009·Journal of Clinical Microbiology·Emmanuelle ChapeyFrançois Peyron
Aug 8, 2021·International Journal of Molecular Sciences·Young Yun JungKwang Seok Ahn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.